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Results: Both CH and glycine were able to counteract the
zymosan-induced ear swelling at 3 h after zymosan injection in
a concentration depending manner. This effect was accompanied
by a concentration dependent increase in the levels of free serum
glycine and a decrease in the production of pro-inﬂammatory cy-
tokines. The CH effects were less pronounced compared to the
glycine effects.
Conclusions: The present study indicates that CH is able to
display an anti-inﬂammatory activity. The reduction of pain by CH,
as indicated in several clinical studies in patients with OA, could
at least partially origin from the anti-inﬂammatory capacity of CH.
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N. Halperin3, R. Debi3
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Purpose: The management of knee Osteoarthritis (KOA) is
presently focused on reducing the level of pain and disability. Mus-
cle weakness and proprioception difﬁculties have been related to
KOA severity, level of pain and disability and are an integral focus
of the therapeutic program for KOA patients. A novel biomechan-
ical device (APOS system) designated to strengthen and train
neuromuscular control was shown to reduce knee adduction mo-
ment. The purpose of the current study was to investigate the
clinical effect of this biomechanical device on patients with KOA.
Methods: 47 patients with bilateral KOA were enrolled to the study.
Patient underwent a gait test and completed the WOMAC Index
and the SF-36 health survey at baseline and after 12 weeks. The
biomechanical device was individually calibrated to each patient
as to allow training under reduced pain. Patients were instructed
to walk with the device on a daily basis for a period of 12 weeks.
Spatio-temporal parameters were used to identify changes in gait
patterns and the questionnaires were used to identify changes in
the reported level of pain, function and quality of life.
Results: Gait velocity, step length and single limb support in-
creased signiﬁcantly following the 3 months of treatment (10%, 6%
Abstract 518 – Figure 1. Production of endogenous hyaluronic synthesis from human synoviocytes with varying intervention concentrations at two time periods.
and 1%, respectively). In addition, WOMAC-Pain and WOMAC-
Function signiﬁcantly decreased (22% and 24%, respectively),
and SF-36 score signiﬁcantly increased (14%) (P<0.001 for all
parameters).
Conclusions: Our results suggest an overall improvement in the
gait pattern, level of pain and functional condition of patients with
KOA following 12 weeks of treatment with the novel biomechanical
device.
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Purpose: Hyaluronic acid (HA) is a heteropolysaccharide present
in synovial ﬂuid and in extracellular matrix of cartilage. HA is
synthesized by human synoviocytes and chondrocytes, and is re-
sponsible for the viscosity of articular synovial ﬂuid. Synovial ﬂuid
has mechanical properties and biochemical properties such as: 1)
Inhibition of prostaglandin E2 and synthesis of nitric oxide (NO)
induced by IL-1. 2) Protection against proteoglycan depletion. 3)
Protection against cytotoxicity induced by oxygen-derived free rad-
icals and NO-induced apoptosis. 4) Affects on leukocyte function.
5) The suppression of cartilage-matrix degradation. 6) Stimula-
tion of the synthesis of endogenous HA. In patients with OA,
the concentration of endogenous HA in synovial ﬂuid decreases
signiﬁcantly. Intra-articular administration of exogenous HA is a
therapeutic option currently in use to treat grades II-III knee OA
patients. We therefore conceived the present study, to ﬁnd out
whether the compounds IB0004 (a natural rooster comb extract
rich in HA) and ID386 (avian hydrolyzed collagen with low HA
content) stimulate the synthesis of endogenous hyaluronic acid in
human osteoarthritic synoviocytes.
Methods: To study the effect of IB0004 and ID386, Human syn-
oviocytes from OA synovial tissue were prepared by enzymatic
digestion, isolated, and cultivated in RPMI supplemented with 10%
S278 Poster Presentations
FCS, 1% P/S and 1% L-glutamine. The synoviocytes (100,000
cells per well on a plate with 24 wells with 250 μl of culture
medium) were incubated with IB0004 and ID386 for 12 and 24
hours at concentrations of 1 μg/mL, 10 μg/mL, 100 μg/mL, 200
μg/mL. ID386 was also tested at a concentration of 1000 μg/mL.
Prescription, pure HA extract was used as a positive control at a
concentration of 200 μg/mL. Negative control was the synoviocyte
culture alone. After incubation, the supernatant was then collected
from the different wells. The endogenous HA (eHA) content was
measured by ELISA (Corgenix Inc., USA). The results are pre-
sented as the mean ± SD of the 9 individual experiments carried
out in the cultures. Statistical analysis was performed using Stu-
dent’s two-tailed t-test for unpaired data, p values were calculated
versus baseline eHA levels.
Results: Baseline levels of endogenous HA in the cell cultures
with no interventions were 710 (±107) and 1867 (±335) ng/ml
after 12 and 24 hours treatment, respectively. As expected, the
positive control group resulted in a signiﬁcant production of eHA
(p<0.05). IB0004 dose dependently induced the expression of
endogenous HA in human OA synoviocytes after 12 h and 24
h treatment. Human OA synoviocytes treated with 100 μg/ml of
IB0004 for 12 h and 24 h produced 49,166 (±2,888, p<0.05)
and 50,300 (±2,648, p<0.05) ng/ml endogenous HA, respectively.
OA synoviocytes stimulated with 200 μg/ml of IB0004 for 12 and
24 h produced 104,625 (±3,159, p<0.05) and 110,454 (±15,666,
p<0.05) ng/ml endogenous HA, respectively. ID386 stimulated
OA synoviocytes at 1000 μg/ml produced only 1,702 (±139) and
2,489 (±176) ng/ml for 12 h and 24 h treatment, respectively, with
even lower amounts of eHA produced at the lower concentrations
(p= n.s. for all ID386 groups). See Figure 1.
Conclusions: IB0004 treatment of OA synoviocytes signiﬁcantly
increased endogenous HA production in a dose dependent man-
ner, and the most effective dose was 200 μg/ml, whereas, ID386
had a negligible effect on the production of endogenous HA, even
at the dose of 1000 μg/ml.
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THERAPEUTIC POTENTIAL OF ORTHOSES FOR
OSTEOARTHRITIS OF THE KNEE DURING ACTIVITY OF
DAILY LIVING AND GOLF
L.L. Johnson, N. Steklov, S. Patel, D. D’Lima
Shiley Ctr. for Orthopedic Res. and Ed., La Jolla, CA
Purpose: The purpose of this study was to determine the in vivo
loads across the knee joint during activities of daily living and in
golf.
Methods: Three patients with electronic sensors in their knee
replacement implants were tested during activities of daily living
and during the golf swing.
Results: The results showed the axial loads for normal walking are
2.5 times body weight with each step. Axial unloading was possible
with a novel proprietary insole. A cane in the opposite hand
reduced the load up to 66% on affected knee. Medial and lateral
compartment loads were dependent on the axial alignment of
the knee. Compartment unloading was possible with a cushioned
wedged insole up to 50% in one subject. An unloader brace
had no effect on lateral compartment unloading during gait or
the golf swing. The loads during the golf swing are much higher
than anticipated, being simultaneously at ball impact 3.25 × body
weight on the back knee while 4.5 × body weight on the front knee.
Unloading during the golf swing is possible with use of cushioned
wedged insoles, shoes with soft spikes and use of shorter golf
club during extended practice.
Conclusions: Abnormal loading of the knee joint may result
in osteoarthritis. The medical literature supports the notion that
unloading the knee may have a therapeutic effect on the os-
Figure 1
Figure 2
teoarthritic knee. This information should be a helpful adjunct for
non-operative management of the patient with osteoarthritis of the
knee.
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COMPARATIVE EFFICACY OF IB0004, EXTRACTED
HYALURONIC ACID (HA) AND FERMENTED HA ON THE
SYNTHESIS OF ENDOGENOUS HA BY HUMAN
SYNOVIOCYTES
A. Torrent1, R. Ruhí1, J. Theodosakis2, F.J. Blanco1,3
1Bioiberica, S.A., Barcelona, Spain; 2Univ. of Arizona, Tucson, AZ;
3Unidad de Investigación, CHU Juan Canalejo, A Coruña, Spain
Purpose: Hyaluronic acid (HA) is a main glycosaminoglycan
present in synovial ﬂuid, synthesized by synovial ﬁbroblasts and
chondrocytes. HA provides a variety of mechanical and biochem-
ical properties. Osteoarthritis (OA) patients exhibit a low endoge-
nous HA and intra-articular administration of HA (either from
extraction or fermentation) is currently an accepted therapy for
OA. One of the proposed mechanisms of action for exogenous HA
is the production of endogenous HA. This study was performed
to determine the in-vitro effects of three compounds: IB0004 (a
natural rooster comb extract rich in HA designed for oral ad-
ministration), extracted HA (HA-E) and fermented (HA-F), both
injectable products, on the synthesis of endogenous HA (eHA) in
human synoviocytes.
Methods: Cultured human synoviocytes obtained from patients
undergoing joint replacement. The synovial tissue was cut into 2
mm3 fragments and washed three times with culture medium (2%
RPMI P/S/A). The synovium was digested by adding 25 mL of
